Opendata, web and dolomites

BIOTIMA

Market Opportunity Confirmation for Biomimetic Tissue Matrix Products

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BIOTIMA project word cloud

Explore the words cloud of the BIOTIMA project. It provides you a very rough idea of what is the project "BIOTIMA" about.

fabrication    alternatives    substrates    medicine    replication    free    tools    inhumane    piloted    versatile    tissue    closely    hydrogel    matrix    biomimetic    functional    pending    scaling    adopter    morphology    vitro    cells    patterned    expensive    toxicity    nano    environments    primary    efficient    preparation    composition    roadmap    elaboration    experiment    optically    material    variety    cosmetics    scientists    clear    patent    discovery    reflect    reduce    tissues    industry    predictive    native    demonstrated    biosynthetic    physiologically    modified    properly    regeneration    solution    models    innovative    animal    feasibility    commercialization    ferentis    thorough    biocompatible    effort    made    materials    human    prepare    standard    mimicking    artificial    employing    seeded    prototypes    lack    business    analyze    clinically    map    customers    stable    culture    functionally    tm    drug    biotima    techniques    cell    nanoengineering    plan    advantages    regenerative    versatility    market    confirm    bioplastic    deposited    surface    lab    organs   

Project "BIOTIMA" data sheet

The following table provides information about the project.

Coordinator
FERENTIS 

Organization address
address: SAVANORIU 231
city: VILNIUS
postcode: 2300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Lithuania [LT]
 Project website http://www.ferentis.eu
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-02-01   to  2015-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FERENTIS LT (VILNIUS) coordinator 50˙000.00

Map

 Project objective

A variety of in vitro human tissue models are used in the fields of testing of cosmetics products, drug discovery and regenerative medicine. Most models made from artificial materials do not properly reflect the native tissue morphology and cell composition, while those made of seeded cells/tissues of specific organs lack versatility and are expensive to use. Ferentis’ Biomimetic Tissue Matrix (BIOTIMA) project addresses the need for efficient toxicity testing/cell culture tools enabling more physiologically relevant, predictive and functional tissue mimicking models, that should become the EU standard in its effort to reduce expensive and inhumane animal testing. Ferentis scientists have developed an innovative patent-pending biosynthetic material –a bioplastic- that is cell-free, stable, biocompatible and optically clear and has demonstrated clinically to promote regeneration of cells. By employing advanced surface nanoengineering techniques, this biosynthetic hydrogel can be deposited, functionally modified and patterned on different substrates, for a variety of lab tissue experiment applications. The unique advantages of our tissue matrix include unique biomimetic properties, most closely mimicking those of the real tissue, and advanced nano-fabrication methods, allowing a cost efficient, versatile and easy to use solution. The prototypes of our TM cell culture tools have been demonstrated in relevant testing environments and now are being piloted with our early adopter customers, with a primary focus on the cosmetics industry. A thorough feasibility study and an elaboration of a business plan is needed in order to analyze the market, map and confirm commercialization alternatives and prepare the roadmap for scaling-up in preparation for Phase II, market replication.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOTIMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOTIMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More  

InLineNano (2015)

In-Line Areal Surface Measurement for Micro and Nano Production

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More